Isoprostanes: New markers for oxidative stress in human disease;Isoprostanes: Nouveaux marqueurs du stress oxydant en pathologie humaine

Presse Medicale

Volumn 29, Issue 11, 2000, Pages 604-610

  Cracowski, J L ^a   Stanke Labesque, F ^a   Souvignet, C ^a   Bessard, G ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROSTANE;

ALZHEIMER DISEASE; DIABETES MELLITUS; HUMAN; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LIVER CIRRHOSIS; OXIDATIVE STRESS; QUANTITATIVE DIAGNOSIS; REVIEW; THROMBOCYTE FUNCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS; DINOPROST; FEMALE; FREE RADICALS; HUMANS; HYPERCHOLESTEROLEMIA; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; LIVER DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; OXIDATIVE STRESS; PROGNOSIS; RISK FACTORS; SMOKING;

EID: 0034712555     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Moore K, Roberts Il LJ. Measurement of lipid peroxidation. Free Rad res 1998 ; 28:659-71.
2. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990 ; 87:9383-7.
3. 2α: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol 1996 ; 42:15-9.
4. Davi G, Ciabattoni G, Consoli A et al. In vivo formation of 8-isoprostaglandin F2a and platelet activation in diabetes mellitus: effets of improved metabolic control and vitamin E supplementation. Circulation 1999 ; 99:224-9.
5. - terolemia. Arterioscler Thromb Vasc Biol 1997 ; 17:3230-5.
6. 2α generation during coronary reperfusion. Circulation 1997 ; 95:2492-9.
7. 2α. J Biol Chem 1995 ; 270:9800-8.
8. 2α during cyclo-oxygenase inhibition in rats but not in man. Br J Pharmacol 1997 ; 121:1770-4.
9. 2α excretion in man. J Pharm Exp Therapeut 1995 ; 275:94-100.
10. Rokach J, Khanapure SP, Hwang SW, Adiyaman M, Lawson JA, Fitzgerald GA. Nomenclature of isoprostanes: a proposal. Prostaglandins 1997 ; 54:853-73.
11. Taber DF, Morrow JD, Robert Il LJ. A nomenclature system for the isoprostanes. Prostaglandins 1997 ; 53:63-7.
12. 2α). Eur J Pharmacol (sous presse).
13. 2α is not mediated by thromboxane receptor isoforms. J Biol Chem 1996 ; 21:14916-24.
14. 2α. Br J Pharmacol 1996 ; 119:1276-80.
15. 2α on retinal vessels. Am J Physiol 1998 ; 274:R1406-16.
16. 2. Adv Prostaglandin Thromboxane Leukot Res 1995 ; 23:237-9.
17. 2α: an index for oxidative injury via free radical catalysed peroxidation. Prostaglandins Leukot Essent Fatty Acids 1998 ; 58:319-25.
18. Pratico D, Barry OP, Lawson JA, Adiyaman M, Hwang SW, Khanapure SP et al. IPF2alpha-I: an index of lipid peroxydation in humans. Proc Natl Acad Sci USA 1998 ; 95:3449-54.
19. 2α in acute coronary angioplasty. Circulation 1997 ; 96:3314-20.
20. Roberts Il LJ, Morrow JD. The generation and action of isoprostanes. Biochim Biophys Acta 1997 ; 1345:121-35.
21. 2α in humans. J Biol Chem 1996 ; 271:20617-6020.
22. 2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem 1999 ; 269:326-31.
23. Reilly M, Delanty N, Lawson JA, Fitzgerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996 ; 94:19-25.
24. 2-isoprostanes) in smokers. N Engl J Med 1995 ; 332:1198-203.
25. Oguogho A, Karanikas G, Kritz H, Riehs G, Wagner O, Sinzinger H. 6-oxo-PGF1alpha and 8-epi-PGF2alpha in human atherosclerotic vascular tissue. Prostaglandins Leukot Esent Fatty Acids 1999; 60:129-34.
26. 2-isoprostanes and reduces prostacydin and nitric oxide in umbilical vessels. Prostaglandins Other Lipid Mediat 1999;57:269-79.
27. 2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997 ; 100:2028-34.
28. 2 isoprostanes in hypercholesterolemia. Circulation 1998; 98:2822-8.
29. Voutilainen S, Morrow JD, Roberts Il LJ et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999 ; 19:1263-6.
30. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995 ; 368:225-9.
31. 2-isoprostanes, are present in increased amounts in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1997 ; 17:3236-41.
32. 2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin invest 1999 ; 103:421-7.
33. 2α in pericardial fluid of patients with heart failure. Circulation 1998 ; 97:1536-9.
34. Van Kooten F, Ciabattoni G, Patrone C, Dipple DW, Koudstaal PJ. Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke 1997 ; 28:1557-63.
35. 2-isoprostanes in Alzheimer's disease:evidence for enhanced lipid peroxidation in vivo. FASEB J 1998; 12:1777-83.
36. 2-isoprostane concentration in probable AD. Neurology 1999 ; 52:562-5.
37. 2 isoprostanes levels are increased in Alzheimer's disease. Ann Neurol 1998 ; 44:410-3.
38. 2α an index of oxidant stress. Am J Respir Crit Care Med 1998 ; 158:1709-14.
39. Montuschi P, Corradi M, Ciabattoni C, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma Patients. Am J Respir Crit Care Med 1999 ; 160:216-20.
40. Montuschi P, Ciabattoni G, Paredi P et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998 ; 158(5 Pt 1): 1524-7
41. 2 alpha isoprostane in cystic fibrosis. Lipids 1999 ; 34:551-6.
42. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998; 114:1653-9.
43. Stein CM, Tanner SB, Awad JA, Roberts LJ, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in sderoderma. Arthritis Rheum 1996; 39:1146-50.
44. Iuliano L, Pratico D, Ferro D et al. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood 1997 ; 90:3931-5.
45. Pratico D, Ferro D, Iuliano L et al. Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation. Blood 1999 ; 93:3401-7.
46. 2 receptors. J Clin Invest 1992 ; 90:136-41.
47. Pratico D, Iuliano L, Basili S et al. Enhanced lipid peroxidation in hepatic cirrhosis. J Invest Med 1998 ; 46:51-7.
48. Ferro D, Basili S, Pratico D, Iuliano L, FitzGerald GA, Violi F. Vitamin E reduces monocyte tissue factor expression in cirrhotic patients. Blood 1999 ; 93:2945-50.
49. 2-isoprostane excretion in alcoholic liver disease. Free Radic Biol Med 1999 ; 26:656-60.